The global leukocyte adhesion deficiency (LAD) treatment market is experiencing substantial growth. This rise can be attributed to a number of factors, including an increasing global population, escalating awareness about LAD, and advancements in therapy options. The market is further stimulated by a thriving research and development landscape, lea